This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.

Accept
Creating a Future Immune to

Immunotherapy is the most promising cancer treatment of our time.
With your support, we can fund more breakthrough research
and more cures for cancers of all kinds.
Why Immunotherapy Support the Cause
87 Cents of every dollar spent goes to programs
All Cancers can potentially be treated with immunotherapy
$30.2 Million awarded in 2020
3,400+ scientists supported globally

We are the Cancer Research Institute

Since 1953, we've led the field with support for immunotherapy research and clinical trials. Together with our donor, patient, and scientist communities, we continue to fund revolutionary breakthroughs to cure all types of cancer.

Learn more about our strategy and impact

Why Cancer Immunotherapy?

By harnessing the innate powers of the body's immune system, immunotherapy treatments have the potential to achieve complete, long-lasting remissions and cures for all types of cancer. Immunotherapy is already saving lives, and while responses vary from patient to patient, with further research, we can bring more effective treatments to more cancer patients.

See how immunotherapy works

Funding the Best Scientists

See Where Your Money Goes

All Together for Team CRI

Fundraise for immunotherapy

I'm the Answer to Cancer

Share Stories and Connect

Partners in Progress

Become a corporate sponsor

News & Events

September 15, 2020
ESMO20 Preview: Immunotherapy Updates
The latest results from a variety of immunotherapy trials will be revealed during ...
Read Article
September 08, 2020
Immunotherapy for Gynecologic Cancers
For Gynecologic Cancer Awareness Month, CRI spoke with Dr. Kunle Odunsi about immu...
Read Article
September 29, 2020
Innovators in Science and Philanthropy
Join us on September 29, for the first-ever CRI Virtual Awards Gala, hosted by Joe...
Read More
September 18, 2020
IO Pipeline Continues Significant Growth
Immunotherapy drug development pipeline continues significant growth in 2020 despi...
Read Release

*Immunotherapy results may vary from patient to patient.

Contact Us

Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111

800-992-2623212-832-9376Staff Directory

Stay Connected with CRI

Follow us

Recent Blog Posts

This September for Childhood Cancer Awareness Month, we look at how we’re working toward a future immune to childhood cancer. 

This September for Blood Cancer Awareness Month, we look at how we’re working toward a future immune to leukemia, lymphoma, and multiple myeloma. 
Top